These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16914206)

  • 41. Imagined ugliness: a symptom which can become a disorder.
    Castle DJ; Morkell D
    Med J Aust; 2000 Aug; 173(4):205-7. PubMed ID: 11008595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Body Dysmorphic Disorder and Surgeon Diagnostic Accuracy in Facial Plastic and Oculoplastic Surgery Clinics.
    Joseph AW; Ishii L; Joseph SS; Smith JI; Su P; Bater K; Byrne P; Boahene K; Papel I; Kontis T; Douglas R; Nelson CC; Ishii M
    JAMA Facial Plast Surg; 2017 Jul; 19(4):269-274. PubMed ID: 27930752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability and Validity of the Self-Report Version of the Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder.
    Patel TA; Summers BJ; Wilver NL; Cougle JR
    Assessment; 2023 Sep; 30(6):1935-1946. PubMed ID: 36114713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria?
    Schieber K; Kollei I; de Zwaan M; Martin A
    J Psychosom Res; 2015 Mar; 78(3):223-7. PubMed ID: 25595027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The frequency of the psychiatric symptoms in the patients with dyspepsia at a university hospital.
    Guz H; Sunter AT; Bektas A; Doganay Z
    Gen Hosp Psychiatry; 2008; 30(3):252-6. PubMed ID: 18433657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Axis I comorbidity in body dysmorphic disorder.
    Gunstad J; Phillips KA
    Compr Psychiatry; 2003; 44(4):270-6. PubMed ID: 12923704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
    Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
    J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body dysmorphic disorder in patients with obsessive-compulsive disorder: prevalence and clinical correlates.
    Conceição Costa DL; Chagas Assunção M; Arzeno Ferrão Y; Archetti Conrado L; Hajaj Gonzalez C; Franklin Fontenelle L; Fossaluza V; Constantino Miguel E; Rodrigues Torres A; Gedanke Shavitt R
    Depress Anxiety; 2012 Nov; 29(11):966-75. PubMed ID: 22815241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between anxiety disorders and dimensional representations of DSM-IV personality disorders: A co-twin control study.
    Welander-Vatn A; Ystrom E; Tambs K; Neale MC; Kendler KS; Reichborn-Kjennerud T; Knudsen GP
    J Affect Disord; 2016 Jan; 190():349-356. PubMed ID: 26544619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics.
    Dyl J; Kittler J; Phillips KA; Hunt JI
    Child Psychiatry Hum Dev; 2006; 36(4):369-82. PubMed ID: 16741679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.
    Simeon D; Hollander E; Stein DJ; Cohen L; Aronowitz B
    Am J Psychiatry; 1995 Aug; 152(8):1207-9. PubMed ID: 7625473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comorbid personality impairment in body dysmorphic disorder.
    Cohen LJ; Kingston P; Bell A; Kwon J; Aronowitz B; Hollander E
    Compr Psychiatry; 2000; 41(1):4-12. PubMed ID: 10646612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validity of the family history method for diagnosing schizophrenia, schizophrenia-related psychoses, and schizophrenia-spectrum personality disorders in first-degree relatives of schizophrenia probands.
    Fogelson DL; Nuechterlein KH; Asarnow RF; Payne DL; Subotnik KL
    Schizophr Res; 2004 Jun; 68(2-3):309-17. PubMed ID: 15099612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective pilot study of levetiracetam for body dysmorphic disorder.
    Phillips KA; Menard W
    CNS Spectr; 2009 May; 14(5):252-60. PubMed ID: 19407724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open-label study of citalopram in body dysmorphic disorder.
    Phillips KA; Najjar F
    J Clin Psychiatry; 2003 Jun; 64(6):715-20. PubMed ID: 12823088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Personality disorders and somatization in functional and organic movement disorders.
    Defazio G; Pastore A; Pellicciari R; Pierri G; Gigante AF; Fabio G; Superbo M; Margari F
    Psychiatry Res; 2017 Nov; 257():227-229. PubMed ID: 28780279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Facial attractiveness ratings and perfectionism in body dysmorphic disorder and obsessive-compulsive disorder.
    Buhlmann U; Etcoff NL; Wilhelm S
    J Anxiety Disord; 2008; 22(3):540-7. PubMed ID: 17624717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DSM-III personality disorder diagnoses in a nonpatient sample. Demographic correlates and comorbidity.
    Zimmerman M; Coryell W
    Arch Gen Psychiatry; 1989 Aug; 46(8):682-9. PubMed ID: 2751402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Standardized assessment of personality disorders in obsessive-compulsive disorder.
    Baer L; Jenike MA; Ricciardi JN; Holland AD; Seymour RJ; Minichiello WE; Buttolph ML
    Arch Gen Psychiatry; 1990 Sep; 47(9):826-30. PubMed ID: 2393341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A psychometric analysis of the social-interpersonal and cognitive-perceptual items for the schizotypal personality disorder.
    Widiger TA; Frances A; Trull TJ
    Arch Gen Psychiatry; 1987 Aug; 44(8):741-5. PubMed ID: 3632246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.